This is an execution-led scale story: the key upside is turning
contract manufacturing capacity into steady shipments (not just pilot wins), while monetizing defensible IP through selective licensing and premium, trusted supply for defense/aerospace. If shipment reliability becomes repeatable, Amprius can grow into broader robotics and high-performance mobility, but the market should still
discount dilution and commoditization risk.